As AI integrates into daily life, remote connectivity is transforming from an IT support tool into a core part of modern ...
Protara Therapeutics (NASDAQ:TARA) shared updated interim data from its ongoing Phase 2, open-label ADVANCED-2 trial evaluating intravesical TARA-002 in patients with high-risk non-muscle invasive ...
Alphabet’s Google (NasdaqGS:GOOGL) is expanding its U.S. data center footprint through new long term clean energy agreements ...
Alphabet's Google doubled down on efforts to secure power supply for its data centers across the country by entering into ...
Palvella Therapeutics (PVLA) stock jumps as a Phase 3 trial for the company's lead asset, Qtorin rapamycin, hits key endpoints against a rare skin disorder. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results